TY - JOUR
T1 - Baicalein, a natural flavonoid in gastrointestinal cancers treatment
T2 - recent trends and future perspectives
AU - Sharma, Pooja
AU - Pal, Deeksha
AU - Gill, Anita Rani
AU - Gupta, Mahiti
AU - Goyal, Soniya
AU - Bansal, Poonam
AU - Sharma, Ujjawal
AU - Mathkor, Darin Mansor
AU - Haque, Shafiul
AU - Kaur, Damandeep
AU - SinghTuli, Hardeep
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024.
PY - 2025/1
Y1 - 2025/1
N2 - Gastrointestinal cancer is a malignant condition of the gastrointestinal tract (GI) which affect multi-organs of digestive system, such as esophagus, stomach, biliary system, pancreas, small intestine, large intestine, rectum, and anus. Gastrointestinal cancer is a 5th most common malignant cancer and 4th major cause in cancer-related mortality rate. Various significant facilities are available that have reduced the radio-resistance, chemo-resistance, and their adverse side effects. However, there are serious side effects associated with chemical and radiations during the process. Baicalein is a natural flavonoid extracted from dried roots of Scutellaria baicalensis, showing anti-cancerous property. It is also participating in inhibiting metastasis, accelerating apoptosis and elevating autophagy through inhibition of inflammation and cell proliferation. In this review, we have focused on Chemistry and pharmacokinetics of Baicalein for drug designing and clinical applications majorly in gastrointestinal cancer. Moreover, various types of cancer related to gastrointestinal, role of nanotechnology, and its synergism for reducing cancer are also discussed. Thus, the review would be beneficial to explore the role of baicalein against gastrointestinal cancer treatment.
AB - Gastrointestinal cancer is a malignant condition of the gastrointestinal tract (GI) which affect multi-organs of digestive system, such as esophagus, stomach, biliary system, pancreas, small intestine, large intestine, rectum, and anus. Gastrointestinal cancer is a 5th most common malignant cancer and 4th major cause in cancer-related mortality rate. Various significant facilities are available that have reduced the radio-resistance, chemo-resistance, and their adverse side effects. However, there are serious side effects associated with chemical and radiations during the process. Baicalein is a natural flavonoid extracted from dried roots of Scutellaria baicalensis, showing anti-cancerous property. It is also participating in inhibiting metastasis, accelerating apoptosis and elevating autophagy through inhibition of inflammation and cell proliferation. In this review, we have focused on Chemistry and pharmacokinetics of Baicalein for drug designing and clinical applications majorly in gastrointestinal cancer. Moreover, various types of cancer related to gastrointestinal, role of nanotechnology, and its synergism for reducing cancer are also discussed. Thus, the review would be beneficial to explore the role of baicalein against gastrointestinal cancer treatment.
KW - Baicalein
KW - Cancer
KW - Gastrointestinal
KW - Nanotechnology
KW - Pharmacokinetics
KW - Scutellaria baicalensis
UR - https://www.scopus.com/pages/publications/85212847686
U2 - 10.1007/s12032-024-02587-z
DO - 10.1007/s12032-024-02587-z
M3 - Artículo de revisión
C2 - 39718726
AN - SCOPUS:85212847686
SN - 1357-0560
VL - 42
JO - Medical Oncology
JF - Medical Oncology
IS - 1
M1 - 35
ER -